Special Issue "New Frontiers in Breast Cancer Diagnosis and Treatment"
Deadline for manuscript submissions: 30 December 2021.
Interests: radiology; breast cancer; breast imaging; oncology; radiomics; artificial intelligence
Interests: transitional oncology; liquid biopsy; breast cancer; lung cancer; phase I
Breast cancer is the most prevalent cancer among women worldwide. In recent decades, there substantial advances in screening methods, early diagnosis, and breakthroughs in treatments have increased survival rates among women with breast cancer. Particularly, advances in medical imaging and genetic knowledge and introduction of artificial intelligence technology in radiological practice have paved the way to true personalized medicine through an implementation of radiomics, radiogenomics, and liquid biopsy. Similarly, progress in molecular biology and pharmacology has aided toward a better understanding of breast cancer, enabling the design of smarter therapeutics able to target cancer and respond to its microenvironment efficiently.
In this Special Issues, we aim to collect original studies, meta-analysis, reviews, pictorial review, and letters investigating the new frontiers of diagnosis and novel treatment strategies for breast cancer.
Dr. Filippo Pesapane
Dr. Matteo Basilio Suter
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- breast cancer
- personalized medicine
- breast imaging
- artificial intelligence
- transitional oncology